» Articles » PMID: 33863742

Identification of a Novel Subset of Alveolar Type 2 Cells Enriched in PD-L1 and Expanded Following Pneumonectomy

Abstract

Alveolar type 2 (AT2) cells are heterogeneous cells, with specialised AT2 subpopulations within this lineage exhibiting stem cell properties. However, the existence of quiescent, immature cells within the AT2 lineage that are activated during lung regeneration is unknown. mice were used for the labelling of AT2 cells and labelled subpopulations were analysed by flow cytometry, quantitative PCR, assay for transposase-accessible chromatin using sequencing (ATAC-seq), gene arrays, pneumonectomy and culture of precision-cut lung slices. Single-cell RNA-sequencing (scRNA-seq) data from human lungs were analysed.In mice, we detected two distinct AT2 subpopulations, with low tdTomato level (Tom) and high tdTomato level (Tom). Tom cells express lower levels of the AT2 differentiation markers and , while Tom, as mature AT2 cells, show higher levels of , , , and expression. ATAC-seq analysis indicates that Tom and Tom cells constitute two distinct cell populations, with specific silencing of , and cell cycle gene loci in the Tom population. Upon pneumonectomy, the number of Tom but not Tom cells increases and Tom cells show upregulated expression of , , , and compared to Sham. Tom cells overexpress programmed cell death 1 ligand 1 (PD-L1), an immune inhibitory membrane receptor ligand, which is used by flow cytometry to differentially isolate these two subpopulations. In the human lung, data mining of a recent scRNA-seq AT2 data set demonstrates the existence of a population. Therefore, we have identified a novel population of AT2 quiescent, immature progenitor cells in mouse that expand upon pneumonectomy and we have provided evidence for the existence of such cells in human.

Citing Articles

MHC class II of different non-professional antigen-presenting cells mediate multiple effects of crosstalk with CD4T cells in lung diseases.

Wang M, Qiao Y, Wei S, Su Z, Lu H Front Med (Lausanne). 2025; 12:1388814.

PMID: 39897591 PMC: 11782049. DOI: 10.3389/fmed.2025.1388814.


Progress and Gaps in Respiratory Disease Research and Treatment: Highlights of the IRM 2024 in Shanghai.

Zhang J, Dhlamini Q, Guo Q, Quan M, Wu J, Lyu H J Respir Biol Transl Med. 2024; 1(4).

PMID: 39712874 PMC: 11661833. DOI: 10.70322/jrbtm.2024.10021.


Unlocking lung regeneration: insights into progenitor cell dynamics and metabolic control.

Yang J, Li Y, Huang Y, Chen H, Sui P Cell Regen. 2024; 13(1):31.

PMID: 39676102 PMC: 11646969. DOI: 10.1186/s13619-024-00212-y.


Gene-level alignment of single-cell trajectories.

Sumanaweera D, Suo C, Cujba A, Muraro D, Dann E, Polanski K Nat Methods. 2024; 22(1):68-81.

PMID: 39300283 PMC: 11725504. DOI: 10.1038/s41592-024-02378-4.


Novel AT2 Cell Subpopulations and Diagnostic Biomarkers in IPF: Integrating Machine Learning with Single-Cell Analysis.

Yang Z, Yang Y, Han X, Hou J Int J Mol Sci. 2024; 25(14).

PMID: 39062997 PMC: 11277372. DOI: 10.3390/ijms25147754.


References
1.
Lastwika K, Wilson 3rd W, Li Q, Norris J, Xu H, Ghazarian S . Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung Cancer. Cancer Res. 2015; 76(2):227-38. DOI: 10.1158/0008-5472.CAN-14-3362. View

2.
Miyazawa T, Marushima H, Saji H, Kojima K, Hoshikawa M, Takagi M . PD-L1 Expression in Non-Small-Cell Lung Cancer Including Various Adenocarcinoma Subtypes. Ann Thorac Cardiovasc Surg. 2018; 25(1):1-9. PMC: 6388302. DOI: 10.5761/atcs.oa.18-00163. View

3.
Bender Kim C, Jackson E, Woolfenden A, Lawrence S, Babar I, Vogel S . Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell. 2005; 121(6):823-35. DOI: 10.1016/j.cell.2005.03.032. View

4.
Strunz M, Simon L, Ansari M, Kathiriya J, Angelidis I, Mayr C . Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis. Nat Commun. 2020; 11(1):3559. PMC: 7366678. DOI: 10.1038/s41467-020-17358-3. View

5.
Finn J, Sottoriva K, Pajcini K, Kitajewski J, Chen C, Zhang W . Dlk1-Mediated Temporal Regulation of Notch Signaling Is Required for Differentiation of Alveolar Type II to Type I Cells during Repair. Cell Rep. 2019; 26(11):2942-2954.e5. PMC: 6464111. DOI: 10.1016/j.celrep.2019.02.046. View